The Michigan Medical Marihuana Review Panel has recommended 10 conditions be added to the state’s medical cannabis program, according to an MLive report. In all, 22 conditions were submitted for consideration by the panel.
What conditions were approved:
- Arthritis
- Autism
- Chronic pain
- Inflammatory bowel disease
- Obsessive-compulsive disorder
- Parkinson’s disease
- Rheumatoid arthritis
- Spinal cord injury
- Tourette’s syndrome
- Ulcerative colitis
What conditions were denied:
- Anxiety
- Asthma
- Brain injury
- Depression
- Diabetes
- Gastric ulcer
- Panic attacks
- Schizophrenia
- Social anxiety disorder
The panel was deadlocked on three conditions: colitis, organ transplant, and non-severe and non-chronic pain. The board will consider those conditions at a future meeting with the rest of the board present to weigh in and potentially break the tie.
Michigan‘s current regime allows access to the program for patients suffering from 10 specific conditions and other chronic or debilitating diseases and medical conditions, or treatments that produce cachexia or Wasting Syndrome; severe and chronic pain; severe nausea; seizures, including epilepsy; and severe and persistent muscle spasms, such as those characteristic of multiple sclerosis.
Most of the recommendations will be approved or denied by July 10. The final decision is made by Department of Licensing and Regulatory Affairs Director Shelly Edgerton. She has until Aug. 6 to make a decision on the chronic pain condition.
Get daily cannabis business news updates. Subscribe
End
